Cargando…
Late-Onset Inflammatory Bowel Disease-Like Syndrome after Ipilimumab Therapy: A Case Report
BACKGROUND: Antitumor immunotherapy has become a major player in cancer therapy. Ipilimumab is a humanized monoclonal antibody against the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an important downregulator of T-cell activation. Ipilimumab has demonstrated tumor regression and improveme...
Autores principales: | Akel, Reem, Anouti, Bilal, Tfayli, Arafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471790/ https://www.ncbi.nlm.nih.gov/pubmed/28626406 http://dx.doi.org/10.1159/000475709 |
Ejemplares similares
-
Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross-Sectional Study in Beirut, Lebanon
por: Naja, Farah, et al.
Publicado: (2017) -
Cancer-Related Pain: Prevalence, Severity and Management in a Tertiary Care Center in the Middle East
por: Hamieh, Nadine M, et al.
Publicado: (2018) -
Anxiety, Depression and Quality of Life in Breast Cancer Patients in the Levant
por: Akel, Reem, et al.
Publicado: (2017) -
Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Fakhri, Ghina, et al.
Publicado: (2017) -
Burnout among Lebanese Oncologists: Prevalence and Risk Factors
por: Salem, Rana, et al.
Publicado: (2018)